Healthcare Sales & Marketing Network News: gene therapy

Searching News Database: gene therapy

HSMN NewsFeed - 30 Oct 2024
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Oct 2024
Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2024
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital

HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 8 May 2024
Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 29 Apr 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Biopharmaceuticals Diagnostics FDA

HSMN NewsFeed - 17 Apr 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA

HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2023
EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
Diagnostics Regulatory

HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2023
VintaBio Names Jennifer Kingsley Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jul 2023
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
Regenerative Medicine Ophthalmology FDA

HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital

HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 5 Jun 2023
Visgenx Appoints William Pedranti as Chief Executive Officer
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 23 Feb 2023
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 30 Jan 2023
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Regenerative Medicine Ophthalmology FDA

HSMN NewsFeed - 20 Jan 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2022
Curate Biosciences Announces David Backer as Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 23 Nov 2022
BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Valoctocogene Roxaparvovec) for Adults with Severe Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2022
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Regenerative Medicine Neurology Regulatory

HSMN NewsFeed - 3 Nov 2022
Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 31 Oct 2022
Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Sep 2022
COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2022
Insmed Names Drayton Wise Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 May 2022
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 9 May 2022
Marengo Therapeutics Appoints Ke Liu, MD, PhD, and Bruce Chabner, MD, to Key Leadership Roles, Strengthening Marengo's Development Team and Supporting Translation to the Clinic
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Apr 2022
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2022
Elixirgen Therapeutics Partners with Taisho Pharmaceutical on Therapeutics for Aging-Associated Diseases
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Biopharmaceuticals

HSMN NewsFeed - 25 Jan 2022
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients
Regenerative Medicine Ophthalmology FDA

HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Sep 2021
DiNAQOR Appoints Medical Device Leader Mark Dehdashtian to Oversee New U.S.-Based Division, Device Development and Production
Devices Personnel

HSMN NewsFeed - 22 Sep 2021
Dr. Thomas Serena, MD, FACS, FACHM, MAPWCA Has Agreed to be MDM Wound Ventures, Inc's Clinical and Research Director
Devices Wound Care Personnel

HSMN NewsFeed - 20 Sep 2021
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology

HSMN NewsFeed - 6 Sep 2021
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 28 Jul 2021
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2021
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Jul 2021
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Jun 2021
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2021
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
Biopharmaceutical Personnel

HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 18 May 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 May 2021
LogicBio Therapeutics Strengthens Management Team with Key Appointments
Regenerative Medicine Personnel

HSMN NewsFeed - 29 Apr 2021
Capsida Biotherapeutics Debuts with $140 Million of Capital
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2021
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Mar 2021
Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome and Stuttering Clinical Trials
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Mar 2021
BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Feb 2021
PYC Therapeutics Expands U.S. Executive Leadership Team with the Appointment of Glenn Noronha, PhD, as Chief Development Officer
Biopharmaceutical Drug Delivery Personnel

HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel

HSMN NewsFeed - 2 Nov 2020
Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 30 Oct 2020
Sana Biotechnology Announces Acquisition of Oscine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Oct 2020
BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Sep 2020
Targazyme Appoints Jim Caggiano as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2020
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jul 2020
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 2 Jul 2020
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Jun 2020
Poseida Therapeutics Raises $110 Million in Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Jun 2020
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Apr 2020
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2020
enGene Announces Additions to Senior Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Jan 2020
Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jan 2020
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Dec 2019
European Medicines Agency Validates BioMarin's Marketing Authorization Application for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Dec 2019
Encoded Therapeutics Strengthens Senior Leadership Team with Key Appointments in Regulatory and Human Resources Functions
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 19 Nov 2019
Aruvant Appoints William Chou as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2019
Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2019
Tenaya Therapeutics Closes $92 Million Series B Financing
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 1 Oct 2019
Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene Therapy
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Sep 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2019
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Sep 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 31 Jul 2019
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV(R) AAV9 Vector
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 18 Jul 2019
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2019
Cirius Therapeutics Adds to Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 May 2019
BioMarin Announces that Phase 3 Cohort of Valoctocogene Roxaparvovec, Gene Therapy Study in Severe Hemophilia A Met Pre-Specified Criteria for Regulatory Submissions in the U.S. and Europe
Biopharmaceuticals

HSMN NewsFeed - 9 May 2019
Evox Therapeutics Expands Leadership Team With the Appointment of Two Experienced Life Sciences Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2019
ReNeuron Provides Business Update and Results Notification
Regenerative Medicine Ophthalmology Neurology

HSMN NewsFeed - 15 Apr 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Apr 2019
Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2019
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Jan 2019
ImaginAb Announces Strengthening of Board and Executive Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Dec 2018
GenEdit Closes $8.5 million Series Seed Financing
Regenerative Medicine Venture Capital Personnel

HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 24 Sep 2018
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Sep 2018
Kyorin Receives Approval from Japan's Ministry of Health, Labour and Welfare for Vibegron for Overactive Bladder
Biopharmaceuticals Urology Regulatory

HSMN NewsFeed - 30 Aug 2018
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2018
Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder
Biopharmaceuticals Urology Licensing

HSMN NewsFeed - 23 Aug 2018
Tocagen's Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned First Interim Analysis
Biopharmaceuticals Neurology Oncology

HSMN NewsFeed - 21 Aug 2018
Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regenerative Medicine FDA

HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2018
Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 23 Jul 2018
Sangamo Therapeutics to Acquire TxCell
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Jun 2018
Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Jun 2018
Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 May 2018
Genprex Announces $10 Million Private Placement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Apr 2018
Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China Region
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 11 Apr 2018
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
Biopharmaceuticals Oncology Drug Delivery Personnel

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 21 Nov 2017
Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2017
FDA Grants Breakthrough Therapy Designation for BioMarin's Valoctocogene Roxaparvovec (formerly BMN 270), an Investigational Gene Therapy for Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2017
Sigilon Therapeutics Introduces Scientific Advisory Board for Guiding Development of Afibromer(TM) Living Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 4 Sep 2017
Eyevensys Appoints Dr Ronald R. Buggage as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care

HSMN NewsFeed - 24 Jul 2017
Tocagen Receives European Medicines Agency Priority Medicines (PRIME) Designation for Toca 511 in High Grade Glioma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Jul 2017
Audentes Therapeutics Announces Appointment of Fulvio Mavilio, Ph.D. to Vice President Scientific Affairs, Europe
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2017
Industry Veteran Mr. Steve Gannon Joins enGene's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2017
Eiger BioPharmaceuticals Announces Sale of Non-Strategic Assets to Theragene Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 13 Jun 2017
Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Jun 2017
Gamida Cell Appoints Nobel Prize Laureate Professor Roger Kornberg and Immune Oncology Expert Dr. Michael Perry to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2017
Homology Medicines Strengthens Manufacturing and Product Development Expertise with Appointment of Tim Kelly as Senior Vice President, Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2017
GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 1 Mar 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2017
Sangamo Therapeutics Announces Chief Financial Officer Succession
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 21 Feb 2017
BrainStorm Seeking Approval To Distribute NurOwn(R) in Canada
Regenerative Medicine Neurology Regulatory Distribution

HSMN NewsFeed - 9 Feb 2017
AAVP Biosystems Hires Mark Shapiro, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2016
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2016
WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals

HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Mar 2016
Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Mar 2016
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2016
Audentes Therapeutics Appoints Scott W. Morrison to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2016
Editas Medicine Expands Leadership Team with Key Organizational Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 3 Nov 2015
Solid GT Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Sep 2015
Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2015
Editas Medicine Raises $120 Million to Advance Genome Editing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Jul 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
Biopharmaceuticals Ophthalmology Venture Captial

HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Devices Regenerative Medicine Orthopaedic Personnel

HSMN NewsFeed - 9 Jul 2015
Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jun 2015
ViraTherapeutics Raises €3.6 Million in the First Closing of a Series A Financing Round to Advance its Novel Oncolytic Virus Platform
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Jun 2015
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Apr 2015
Alcyone Lifesciences Receives FDA Clearance for MRI-Compatible MEMS Cannula
Devices Interventional Neurology Neurosurgery FDA

HSMN NewsFeed - 25 Mar 2015
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial of VB-111 in Recurrent Glioblastoma (rGBM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2014
Audentes Therapeutics Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Nov 2014
Intellia Therapeutics Announces $15 Million in Funding to Develop Therapeutic Products Utilizing CRISPR-Cas9 Gene Editing Technology
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Sep 2014
Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 30 Jul 2014
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Jun 2014
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jun 2014
Bayer HealthCare and Dimension Therapeutics to Develop Novel Gene Therapy for Hemophilia A
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2014
Dimension Therapeutics Raises $30M Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 2 Apr 2014
Baxter to Acquire Chatham Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Mar 2014
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Feb 2014
Abingworth Raises £225m ($375m) in its Tenth Life Sciences Fund
Biopharmaceuticals Devices Venture Capital

HSMN NewsFeed - 13 Jan 2014
BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2013
Celladon Corporation Appoints Michael Narachi as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2013
Audentes Therapeutics Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Mar 2013
Capricor, Inc. Appoints Anthony Davies, Ph.D., Chief Technology Officer
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 13 Nov 2012
Peter Wirth Named Chairman of the FORMA Therapeutics Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Nov 2012
uniQure's Glybera(R) First Gene Therapy Approved by European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jul 2012
First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Jun 2012
ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 19 Apr 2012
RetroSense Welcomes Dr. Peter Francis as Clinical Director
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 15 Mar 2012
Completed Clinical Trial Further Indicates Cell-in-a-Box(R) Encapsulation Technology Has the Potential to Treat a Wide Array of Solid Tumors
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 30 Jan 2012
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera(R) Marketing Authorisation and Requests Further Information From the CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Jan 2012
Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Nov 2011
Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Jul 2011
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Jun 2011
AVI BioPharma Names Ed Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2011
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 May 2010
SonoSite Announces Definitive Agreement to Acquire Visualsonics
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 May 2010
XYTOS Announces the Appointment of John Trotter II, MD as the Company's New Chief Medical Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
Devices Surgery Regenerative Medicine Personnel

HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Mar 2010
Genetix Pharmaceuticals Secures $35M in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine

HSMN NewsFeed - 19 Jan 2010
QuantRx CEO Provides Update on Genetics-based Personalized Medicine and Disease Prevention Platform Technology
Diagnostics Personalized Medicine

HSMN NewsFeed - 2 Dec 2009
AMT Announces Management Changes in Light of Refocused Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2009
Positive Findings from Excellarate(TM) Phase 1/2 Clinical Study Published in Journal of Wound Repair and Regeneration
Devices Biopharmaceuticals Wound Care

HSMN NewsFeed - 13 Oct 2009
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care

HSMN NewsFeed - 28 Jul 2009
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Regenerative Medicine Wound Care

HSMN NewsFeed - 15 Jun 2009
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2009
The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 24 Feb 2009
Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2008
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
Devices Neurology Venture Capital

HSMN NewsFeed - 10 Nov 2008
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 12 Sep 2008
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
Diagnostics Personnel

HSMN NewsFeed - 10 Sep 2008
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Sep 2008
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 4 Aug 2008
Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director
Regenerative Medicine Personnel

HSMN NewsFeed - 17 Jul 2008
AMT Appoints Director Global Marketing and Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jul 2008
Cortria Corporation Announces Appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2008
Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Biopharmaceuticals Oncology FDA Regulatory

HSMN NewsFeed - 16 Jun 2008
IRX Therapeutics Names Scott M. Freeman, M.D. Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2008
Cook Medical Enters Coronary Stent Market in Europe with New CoCr Stent
Devices Interventional Cardiology

HSMN NewsFeed - 3 Jun 2008
Provectus Pharmaceuticals Appoints Kelly M. McMasters, MD, PhD, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 May 2008
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Apr 2008
Bradmer announces new additions to management team
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2008
Sirtex Announces New President for U.S. Operations
Devices Personnel

HSMN NewsFeed - 20 Mar 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

HSMN NewsFeed - 21 Feb 2008
ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2007
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Nov 2007
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
Devices Wound Care

HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2007
Genzyme Launches Cholestagel(R) in Europe
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Sep 2007
Introgen Presents Biomarker Data Demonstrating Abnormal p53 Predicts ADVEXIN Efficacy in Head and Neck, Lung, Prostate and Li-Fraumeni Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Sep 2007
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Aug 2007
Worldwide Skin-Ulcer Treatment Market to See New Growth, Reaching $6.2 Billion by 2011
Devices Wound Care

HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Biopharmaceuticals

HSMN NewsFeed - 2 Aug 2007
Hollis-Eden Pharmaceuticals Names Scott M. Freeman, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Jun 2007
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jun 2007
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
Devices Neurology Venture Capital

HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 4 Jun 2007
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 May 2007
Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 16 May 2007
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
Biopharmaceuticals

HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Apr 2007
Alba Therapeutics Announces Appointment of Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Apr 2007
Exciting Developments on the Horizon for Parkinson Disease, Says Medical Director for the National Parkinson Foundation
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 20 Feb 2007
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2007
Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jan 2007
Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Jan 2007
Cook Medical Names Rob Lyles as Vice President
Devices Personnel

HSMN NewsFeed - 17 Jan 2007
ImmunoCellular Therapeutics Announces Dr. Keith L. Black, Chairman, Department of Neurosurgery and Director, Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, to Become Chair of its Board of Scientific Advisors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2007
U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
Regenerative Medicine Cardiology

HSMN NewsFeed - 12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 12 Dec 2006
Dr. Jeffrey Leiden Appointed Non Executive Director at Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2006
Northern Therapeutics and MaxCyte Initiate Landmark Engineered Cell Therapy Trial for Fatal Lung Disease
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel

HSMN NewsFeed - 30 Nov 2006
Sirtris Pharmaceuticals Obtains Exclusive Rights to Key Sirtuin Technology from MIT
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Nov 2006
Tacere Therapeutics Appoints Vice President, Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2006
NeoStem, Inc. Appoints Prominent Authority in Cardiology and Stem Cell Research to the Company's Advisory Board
Regenerative Medicine Personnel

HSMN NewsFeed - 3 Nov 2006
Corautus Genetics Announces Redirection of Focus and Transition Of Officers
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 2 Nov 2006
Cohera Medical, Inc. Announces Dr. Doros Platika Elected as Chairman of the Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 30 Oct 2006
QIAGEN Acquires Genaco Biomedical Products, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 24 Oct 2006
Covalon Announces Completed Acquisition of Perfusion Therapeutics' Gene Therapy Technology
Devices Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2006
Introgen's ADVEXIN Molecular Targeted Therapy Is Active in Multiple Cancers; ADVEXIN Regulatory Program Advances
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Oct 2006
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Oct 2006
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2006
AMDL Announces Closing of Jade Pharmaceutical Acquisition
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Sep 2006
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Regenerative Medicine FDA

HSMN NewsFeed - 13 Jul 2006
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 2 Jun 2006
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2006
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 31 May 2006
Corautus Genetics Announces Filing of Response to FDA Clinical Hold
Biopharmaceuticals Devices Drug Delivery Cardiology FDA

HSMN NewsFeed - 26 May 2006
Introgen to Announce Important New Clinical Data for ADVEXIN Cancer Therapy at Major Medical Meetings
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2006
Topical Hedgehog Agonist Accelerates Wound Healing in Diabetes
Biopharmaceuticals Wound Care

HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation

HSMN NewsFeed - 23 Feb 2006
Corautus Genetics Announces Update on GENASIS Trial
Biopharmaceuticals Cardiology

Return to NewsFeed

Additional items found! 183

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 183 additional stories matching:
gene therapy
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.